// App-Quantinova.ai

397 : Rebastinib potently inhibits function of perivascular TIE2 expressing macrophages in vitro and in vivo

Researchers

Presenter

  • Allison Harney

Principal Investigators

  • Jeanine Pignatelli

  • Edison Leung

  • Maja Oktay

  • Yarong Wang

  • Bryan D. Smith

  • Daniel L. Flynn

  • John S. Condeelis

Medical Centers

  • Albert Einstein College of Medicine, Great Neck, NY

Locations

  • United States

Companies

  • Deciphera Pharmaceut

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Angiogenin

  • Circulating tumor cells

  • DNA Damage Inducible Transcript 3

  • Lactate dehydrogenase

Drug/Treatment

  • rebastinib

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final